1 min.Read

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

October 2, 2026

This MedicinMan Intelligence Report follows a disturbing trail—from Arun Bhatia’s action against Glaxo’s Worli unit in 1993 to the 2026 Bidadi raid, Bhagirath Place, and Agra’s medicine mandi. MIR 2nd October MIR 2nd October

But this is not another “fake drugs” story.

India is dealing with three different medicine-quality failures:

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Topics

Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

Free Membership Required

Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

10 Years of Pharma M&A — Who’s Really Benefited?

What’s Killing Patients? Cancer or Rigged Drug Prices?

A Tale of Two Cities: Peptides and Prescriptions

Topics

Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

10 Years of Pharma M&A — Who’s Really Benefited?

What’s Killing Patients? Cancer or Rigged Drug Prices?

A Tale of Two Cities: Peptides and Prescriptions

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

The $1.5 Billion Question in Hyderabad: Orbicular, Peptides and the PE Re-Rating of Indian Complex Generics

Medical Reps—Lessons From The West: The Old Model is Dead

Related Articles

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

10 Years of Pharma M&A — Who’s Really Benefited?

A Tale of Two Cities: Peptides and Prescriptions

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

The $1.5 Billion Question in Hyderabad: Orbicular, Peptides and the PE Re-Rating of Indian Complex Generics

Company

Headlines

Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

10 Years of Pharma M&A — Who’s Really Benefited?

What’s Killing Patients? Cancer or Rigged Drug Prices?

Newsletter